ClinicalTrials.Veeva

Menu

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients (TRASCO)

U

University Hospital Tuebingen

Status

Unknown

Conditions

Primary Open Angle Glaucoma (POAG)

Treatments

Device: Optical Coherence Tomography (OCT)
Device: Perimetry
Device: Confocal Scanning Laser Tomography

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00902109
SCOPE-G-BETA

Details and patient eligibility

About

The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.

Enrollment

12 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • primary open angle glaucoma (POAG)
  • spherical ametropia max. ± 8 dpt
  • cylindrical ametropia max. ± 3 dpt
  • distant visual acuity > 10/20
  • pupil diameter > 3 mm

Exclusion criteria

  • diabetic retinopathy
  • asthma
  • history of epilepsy or significant psychiatric disease
  • medications known to effect visual field sensitivity
  • infections (e.g., keratitis, conjunctivitis, uveitis)
  • severe dry eyes
  • miotic drug
  • squint
  • nystagmus
  • albinism
  • any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields
  • keratoconus
  • intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening
  • history or signs of any visual pathway affection other than glaucoma
  • history or presence of macular disease and/or macular edema, ocular trauma, medications known to affect visual field sensitivity

Trial design

12 participants in 1 patient group

perimetry, HRT, OCT
Description:
perimetry, HRT, OCT
Treatment:
Device: Confocal Scanning Laser Tomography
Device: Perimetry
Device: Optical Coherence Tomography (OCT)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems